Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what guidance he has provided to community pharmacies on the sale of Ibuprofen during the covid-19 outbreak.

The Commission on Human Medicine’s Expert Working Group on COVID-19 has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.

The Expert Working Group’s advice has been published on GOV.UK, and communicated to healthcare professionals including community pharmacists in a joint statement from the Medicines and Healthcare products Regulatory Agency, NHS England, and the National Institute for Health and Care Excellence.

The guidance is available at the following link: https://www.gov.uk/government/news/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19